This page contains a Flash digital edition of a book.
118. Graff LA, Walker JR, Lix LM. The relationship of inflammatory bowel disease type and activity with psychological functioning and quality of life. Clin Gastroentrol Hepatol 2006; 4: 1491-1501.


119. Walker JR, Ediger JP, Graff LA et al. The Manitoba IBD cohort study: a population – based study of the prevalence of lifetime and 12-month anxiety and mood disorders. AM J Gastroenterol 2008; 103: 1989-97.


120. Graff LA, Vincent N, Walker JR et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 1882-9.


121. Vidal A, Gomez-Gil E, Sans M. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 2008; 14: 977-83.


122. Solomon D, Holley D BUch M et al. An international survey of ulcerative colitis: perspectives from patients and healthcare professionals. ECCO abstracts: Barcelona, February 2012


123. Griffiths AM, Nicholas D, Smith C, et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999; 28:S46–S52


124. Loonen HJ, Grootenhuis MA, Last BF. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease-specific instrument. Acta Paediatr 2002; 91: 348-54.


126. Scarpa M, Ruffolo C, D’Inca R et al. Health-related quality of life after ileocolonic resection for Crohn’s disease: long-term results. Inflamm Bowel Dis 2007; 13: 462-9.


127. Camilleri-Brennan J, Steele RJ. Objective assessment of quality of life after panproctocolectomy and ileostomy for ulcerative colitis. Ann R Coll Surg Engl 2001; 83; 321-4.


125. De Boer M, Grootenhuis M, Derkx B et al. Health-related quality of life and psychosocial functioning in adolescent boys with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 400-6.


128. Bernklev T, Jahnsen J, Schulz T et al. Course of disease, drug treatment and health- related quality of life in patients with inflammatory bowel disease five years after initial diagnosis. Eur J Gastroenterol Hepatol 2005; 17: 1037-45.


129. Feagan BG, Rainisch W, Rutgeerts P et al. The effects of infliximab therapy on health- related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007; 102: 794-802.


130. Rutgeerts P, Schreiber S, Feagan B et al. Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNF a, improves health-related quality of life in patients with moderate to severe Crohn’s disease. Int J Colorectal Dis 2008; 23: 289-96.


131. Colombel JF, Loftus EV, Feagan BG et al. Impact of adalimumab (Humira®) on patient- reported outcomes among patients with fistulizing Crohn’s disease in the Charm trial. Gut 2007; 56 (Suppl III): A149.


132. Bernklev T, Jahnsen J, Henriksen M et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 412-12.


133. Feagan BG, Bala M, Yan S et al. Unemployment and disability in patients with moderately to severely active Crohn’s disease. J Clin Gastroenterol 2005; 39: 390-5.


134. Lichtenstein GR, Yan S, Bala M et al. Remission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2003; 1: 91-6.


135. Reinisch W, Sandborn WJ, Bala M et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productive of patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13; 1135-1140.


136. Bernklev T, Jahnssen J, Lygren I. Health-related quality of life in inflammatory bowel disease patients measured with the short-form 36: psychometric assessments and comparison with general population norms. Inflamm Bowel Dis 2005; 11: 908-11.


THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN CANADA 93


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96